Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019–April 2020

PLoS ONE(2021)10.1371/journal.pone.0252235Source: DataRank Database

Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019–April 2020 is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.12)OA: goldTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Michael L. Jackson ORCID,James P. Hughes ORCID,Sandra Lester ORCID,Lisa Mills ORCID,Brandi Freeman ORCID

Live enrichment

PubMed:34043706 PMC:PMC8158900 OpenAlex:https://openalex.org/W3164895575

School of Medicine

Grant: University of Washington Department of Medicine Scholars Award

National Institute of Allergy and Infectious Diseases

Grant: T32 Training Grant 5T32AI007044-43

NIH HHS

Grant: 5T32AI007044-43

Host Defense Training in Allergy and Infectious Diseases

NIAID NIH HHS

Grant: T32 AI007044

FWCI

0.12

Citation Percentile

0.5%

Citation Trend

2021

2022

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0252235&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0252235&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0252235

journalhttps://doi.org/10.1371/journal.pone.0252235

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34043706

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing03 medical and health sciences0302 clinical medicine

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Serological TestingAdultAntibodies, ViralFemaleHumansMaleWashingtonPrevalenceSeroepidemiologic Studies

Keywords

SeroprevalenceSerologyMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)AntibodyOutbreakVirologyImmunologyInternal medicineDiseaseInfectious disease (medical specialty)AdultMaleWashingtonSARS-CoV-2ScienceQRCOVID-19Antibodies, ViralCOVID-19 Serological TestingSeroepidemiologic StudiesPrevalenceHumansFemaleResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019–April 2020

FAIR Checklist

Authors (9)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)